STEPHANIE PAGE, M.D., PH.D.  
Division of Metabolism, Endocrinology and Nutrition Co-Director, UWMedicine Diabetes Institute

Despite a variety of effective, reversible and safe female contraceptives, >40% of pregnancies worldwide, including in the US, are unplanned.  My work aims to develop and evaluate reversible male hormonal contraceptives, allowing men to more fully engage in and share the burden of contraception with their partners to reduce unplanned pregnancy.  Clinical trials of prototype male contraceptives, including a “male pill”, a long-acting injection, and a daily transdermal gel have demonstrated promising results.  Our group is focused on optimizing delivery methods and effectiveness, delineating and minimizing adverse effects and assessing the acceptability and potential societal and cultural effects of male hormonal contraceptives.